<?xml version="1.0" encoding="UTF-8"?>
<ref id="B40-viruses-11-00807">
 <label>40.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hart</surname>
    <given-names>M.K.</given-names>
   </name>
   <name>
    <surname>Caswell-Stephan</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Bakken</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Tammariello</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Pratt</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Davis</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Johnston</surname>
    <given-names>R.E.</given-names>
   </name>
   <name>
    <surname>Smith</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Steele</surname>
    <given-names>K.</given-names>
   </name>
  </person-group>
  <article-title>Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate</article-title>
  <source>Vaccine</source>
  <year>2000</year>
  <volume>18</volume>
  <fpage>3067</fpage>
  <lpage>3075</lpage>
  <pub-id pub-id-type="doi">10.1016/S0264-410X(00)00042-6</pub-id>
  <pub-id pub-id-type="pmid">10825611</pub-id>
 </element-citation>
</ref>
